<?xml version="1.0" encoding="UTF-8"?>
<ref id="B194">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Shah</surname>
    <given-names>P. P.</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Kaletsky</surname>
    <given-names>R. L.</given-names>
   </name>
   <name>
    <surname>Myers</surname>
    <given-names>M. C.</given-names>
   </name>
   <name>
    <surname>Purvis</surname>
    <given-names>J. E.</given-names>
   </name>
   <name>
    <surname>Jing</surname>
    <given-names>H.</given-names>
   </name>
   <etal/>
  </person-group> (
  <year>2010</year>). 
  <article-title>A small-molecule oxocarbazate inhibitor of human cathepsin L blocks severe acute respiratory syndrome and ebola pseudotype virus infection into human embryonic kidney 293T cells.</article-title>
  <source>
   <italic>Mol. Pharmacol.</italic>
  </source>
  <volume>78</volume>
  <fpage>319</fpage>â€“
  <lpage>324</lpage>. 
  <pub-id pub-id-type="doi">10.1124/mol.110.064261</pub-id>
  <?supplied-pmid 20466822?>
  <pub-id pub-id-type="pmid">20466822</pub-id>
 </mixed-citation>
</ref>
